Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schaefer

Showing results (191-200 of 255) with videos related to

Pageof 26
Sort By:
Frontiers in Oncology|March 15, 2024
Corrigendum: Establishment of tumor treating fields combined with mild hyperthermia as novel supporting therapy for pancreatic cancerLiping Bai, Tobias Pfeifer, Wolfgang Gross, et al.
Journal of Cell Science|June 28, 2003
The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of RhoGrazia Tamma, Burkhard Wiesner, Jens Furkert, et al.
Frontiers in Oncology|November 22, 2021
Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic CancerLiping Bai, Tobias Pfeifer, Wolfgang Gross, et al.
Journal of the Cardiometabolic Syndrome|August 7, 2007
A triglyceride/high-density lipoprotein ratio > or = 3.5 is associated with an increased burden of coronary artery disease on cardiac catheterizationRobert Ostfeld, Disha Mookherjee, Michael Spinelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2006
Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cellsHeike L Rittner, Dominika Labuz, Michael Schaefer, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell deathLi Liu, XueFeng An, Michael Schaefer, et al.
Frontiers in Oncology|April 18, 2022
Corrigendum: Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic CancerLiping Bai, Tobias Pfeifer, Wolfgang Gross, et al.
Angewandte Chemie (International Ed. in English)|June 17, 2022
BTDAzo: A Photoswitchable TRPC5 Channel ActivatorMarkus Müller, Konstantin Niemeyer, Nicole Urban, et al.
Scientific Reports|April 18, 2018
Incidental haptic sensations influence judgment of crimesMichael Schaefer, Lillia Cherkasskiy, Claudia Denke, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl <i>N</i>-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in MiceXiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz, et al.
Pageof 26

Showing results (191-200 of 255) with videos related to

Sort By:
Pageof 26
Frontiers in Oncology|March 15, 2024
Corrigendum: Establishment of tumor treating fields combined with mild hyperthermia as novel supporting therapy for pancreatic cancerLiping Bai, Tobias Pfeifer, Wolfgang Gross, et al.
Journal of Cell Science|June 28, 2003
The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of RhoGrazia Tamma, Burkhard Wiesner, Jens Furkert, et al.
Frontiers in Oncology|November 22, 2021
Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic CancerLiping Bai, Tobias Pfeifer, Wolfgang Gross, et al.
Journal of the Cardiometabolic Syndrome|August 7, 2007
A triglyceride/high-density lipoprotein ratio > or = 3.5 is associated with an increased burden of coronary artery disease on cardiac catheterizationRobert Ostfeld, Disha Mookherjee, Michael Spinelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2006
Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cellsHeike L Rittner, Dominika Labuz, Michael Schaefer, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell deathLi Liu, XueFeng An, Michael Schaefer, et al.
Frontiers in Oncology|April 18, 2022
Corrigendum: Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic CancerLiping Bai, Tobias Pfeifer, Wolfgang Gross, et al.
Angewandte Chemie (International Ed. in English)|June 17, 2022
BTDAzo: A Photoswitchable TRPC5 Channel ActivatorMarkus Müller, Konstantin Niemeyer, Nicole Urban, et al.
Scientific Reports|April 18, 2018
Incidental haptic sensations influence judgment of crimesMichael Schaefer, Lillia Cherkasskiy, Claudia Denke, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl <i>N</i>-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in MiceXiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz, et al.
Pageof 26